Profusa, Inc. (NASDAQ:PFSA) Stock Short Interest Report for September

Profusa, Inc. (NASDAQ:PFSA) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totaling 160,653 shares, an increase of 409.3% from the September 15th total of 31,545 shares. Based on an average trading volume of 9,017,408 shares, the short-interest ratio is currently 0.0 days. Approximately 31.2% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

PFSA has been the subject of a number of analyst reports. Wall Street Zen upgraded shares of Profusa to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings raised shares of Profusa from a “sell (e)” rating to a “sell (e+)” rating in a report on Thursday, August 27th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Profusa has a consensus rating of “Sell”.

Insider Activity at Profusa

In other news, major shareholder Financial Lp Hrt sold 10,602 shares of the firm’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $3.56, for a total transaction of $37,743.12. Following the completion of the transaction, the insider directly owned 18,549 shares in the company, valued at $66,034.44. This trade represents a 36.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders acquired 4,308 shares of company stock valued at $16,594 over the last 90 days. Corporate insiders own 15.00% of the company’s stock.

Profusa Trading Down 4.7%

PFSA stock traded down $0.07 during midday trading on Friday, hitting $1.42. The company’s stock had a trading volume of 231,698 shares, compared to its average volume of 5,308,696. The firm’s 50-day moving average is $3.66 and its 200-day moving average is $25.82. Profusa has a 12 month low of $1.40 and a 12 month high of $3,000.00. The company has a market cap of $860,520.00, a PE ratio of -0.00 and a beta of 0.53.

Profusa (NASDAQ:PFSA) last posted its earnings results on Wednesday, August 19th. The company reported ($151.80) EPS for the quarter.

Profusa Company Profile

Profusa, Inc is a biotechnology company developing implantable biosensor technology designed to continuously monitor body chemistry. Its sensors are engineered to integrate with tissue and detect selected biological signals, with the goal of providing real-time health data through an external reader or connected digital device.

The company’s technology platform has been studied for applications including monitoring oxygen and other biomarkers that may assist with disease management, clinical research, and personalized healthcare.